Omeprazol Stada (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Stada, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is used to manage conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease, NSAID‑induced ulcer prophylaxis, and as part of Helicobacter pylori eradication regimens.

GNH USA supplies Omeprazol Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole acts on the gastric proton pump to lower acid production, making it useful for several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Peptic ulcer disease: supports ulcer healing and reduces recurrence. - NSAID‑induced ulcer prophylaxis: lowers risk of ulcer formation in patients on non‑steroidal anti‑inflammatory drugs. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Nausea or abdominal discomfort. - Flatulence: occasional. - Constipation: infrequent. - Dry mouth: mild.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: jaundice or abnormal liver tests. - Interstitial nephritis: kidney inflammation.

Before using Omeprazol Stada, consider the following precautions. - Assess renal function: adjust use in severe impairment. - Review hepatic status: caution in severe liver disease. - Evaluate for infections: monitor for C. difficile if prolonged therapy. - Consider bone health: limit long‑term use in patients at fracture risk. - Pregnancy and lactation: discuss risks with a healthcare professional. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Omeprazol Stada may interact with other medicines; awareness of the interaction level helps manage risk.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir or other protease inhibitors: decreased absorption. - Methotrexate (high dose): increased toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR. - Digoxin: altered serum levels. - Iron or vitamin B12 supplements: reduced absorption; separate dosing by at least 2 hours.